Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L ADA

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Vaccine|April 1, 1988
What to expect of a good vaccine and how to achieve itG L Ada
Journal of Acquired Immune Deficiency Syndromes|January 1, 1988
Prospects for HIV vaccinesG L Ada
Immunology Today|October 8, 2014
Controlling influenza epidemicsG L Ada
World Journal of Microbiology & Biotechnology|January 16, 2014
The ideal vaccineG L Ada
IARC Scientific Publications|January 1, 1982
Host factors important in immune surveillance against tumoursG L Ada
Annals of the Academy of Medicine, Singapore|April 1, 1988
Modern approaches to vaccine development with special reference to the needs of developing countriesG L Ada
Developments in Biological Standardization|January 1, 1994
Human vaccinesG L Ada
Scandinavian Journal of Immunology|July 1, 1985
Influenza virus-specific T cells fail to reduce lung virus titres in cyclosporin-treated, infected miceE Schiltknecht, G L Ada
Cellular Immunology|October 15, 1985
The generation of effector T cells in influenza A-infected, cyclosporine A-treated miceE Schiltknecht, G L Ada
Cellular Immunology|March 1, 1985
In vivo effects of cyclosporine on influenza A virus-infected miceE Schiltknecht, G L Ada
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Vaccine|April 1, 1988
What to expect of a good vaccine and how to achieve itG L Ada
Journal of Acquired Immune Deficiency Syndromes|January 1, 1988
Prospects for HIV vaccinesG L Ada
Immunology Today|October 8, 2014
Controlling influenza epidemicsG L Ada
World Journal of Microbiology & Biotechnology|January 16, 2014
The ideal vaccineG L Ada
IARC Scientific Publications|January 1, 1982
Host factors important in immune surveillance against tumoursG L Ada
Annals of the Academy of Medicine, Singapore|April 1, 1988
Modern approaches to vaccine development with special reference to the needs of developing countriesG L Ada
Developments in Biological Standardization|January 1, 1994
Human vaccinesG L Ada
Scandinavian Journal of Immunology|July 1, 1985
Influenza virus-specific T cells fail to reduce lung virus titres in cyclosporin-treated, infected miceE Schiltknecht, G L Ada
Cellular Immunology|October 15, 1985
The generation of effector T cells in influenza A-infected, cyclosporine A-treated miceE Schiltknecht, G L Ada
Cellular Immunology|March 1, 1985
In vivo effects of cyclosporine on influenza A virus-infected miceE Schiltknecht, G L Ada
Pageof 6